Prescribing restrictions for generic sildenafil removed

The Department of Health has removed restrictions requiring prescribers to endorse prescriptions for the generic erectile dysfunction drug sildenafil.

Restrictions on Viagra have been maintained as its price has not fallen. | SCIENCE PHOTO LIBRARY
Restrictions on Viagra have been maintained as its price has not fallen. | SCIENCE PHOTO LIBRARY

On 1st August, an amendment to the NHS Prescription of Drugs Regulations saw the removal of generic sildenafil from the selected list scheme (SLS), meaning that prescribers are no longer required to endorse prescriptions for the erectile dysfunction drug with 'SLS'.

The change was made following a significant reduction in the price of sildenafil after the expiry of patent protection for Viagra last year. The restrictions continue to apply to branded Viagra and certain other erectile dysfunction therapies such as alprostadil, avanafiltadalafil and vardenafil.

These drugs may be prescribed on the NHS only in certain circumstances, including for men with prostate cancer, kidney failure treated with dialysis or transplantation, spinal cord injury, diabetes, multiple sclerosis, Parkinson's disease, following radical pelvic surgery or prostatectomy, and through specialist services for men suffering severe distress because of impotence.

The generic drugs apomorphine hydrochloride, moxisylyte hydrochloride and thymoxamine hydrochloride have also been removed from the SLS list.

View Erectile dysfunction drug records

Follow MIMS on Twitter

Sign up for MIMS bulletins


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.